MedTrace Logo

Prostate Cancer Symptom Management for Low Literacy Men

NCT00983710 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2018-01-23

No results posted yet for this study

Summary

This study will compare a newly-developed patient education program to help men with localized prostate cancer manage treatment-related side-effects versus usual care. The new intervention will be developed for men with lower health literacy. That means that the education materials will be developed for sixth grade reading level or lower. The materials will include lots of examples and illustrations to make it easier for people understand the information.

Conditions

Interventions

BEHAVIORAL

PC-PEP - Prostate Cancer Patient Education Program

Men in the intervention group will receive a new patient education intervention to help them manage side-effects related to treatment for localized prostate cancer. The intervention will be delivered by phone and by mail and is targeted to me with low health literacy. The intervention consists of written materials, audio materials, and telephone-based problem-solving education.

BEHAVIORAL

Usual care

Booklet on coping with localized prostate cancer

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    collaborator FED

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • David M Latini, PhD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-10-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00983710 on ClinicalTrials.gov